Polymorphisms distribution of phase Ⅱ drug metabolic enzyme gene GSTM1 and GSTT1 in Chinese Han pediatric population

LIU Fang,MIAO Qing,XIAO Jing,SUN Lin,SHEN Chen,JIAO Wei-wei,FENG Wei-xing,WU Xi-rong,SHEN Dan,SHEN A-dong
DOI: https://doi.org/10.3969/j.issn.1673-5501.2011.03.008
2011-01-01
Abstract:Objective Human glutathione S-transferases(hGSTs) play a crucial role in the biological detoxification processes of drugs and xenobiotics.In drug metabolic process,the gene polymorphism caused by a homozygous or heterozygous deletion of the GSTM1 and GSTT1 genes was associated with the metabolic speed of glutathione S-transferases.The aim of this study was to investigate the association between gene polymorphisms and the metabolic phenotype of GSTM1 and GSTT1 in normal Chinese Han children,to provide an important theoretical basis for guiding the clinical treatment of drugs which metabolic by liver.Methods Chinese Han healthy children were identified who were randomly sampled from 2005 to 2010 in healthy center of Beijing Children's Hospital.The mean age of them was 5.425 years,ranged from 2 months to 14 years.The participants with positive history of diagnosed cancers,psychiatric disorders,asthma,cataract and cardiovascular disease showing significant association with hGSTs polymorphism were excluded.Demographic and medical information of these children was obtained from the patients' files.Genomic DNA was extracted from peripheral blood by EDTA anticoagulation,using a standard salting-out procedure.The concentration and purity of DNA were estimated spectrophotometrically.Genotyping was carried out by using traditional PCR-RFLP method.Further comparison between our existing data and previously reported frequencies in other ethnic populations,was performed to determine inter-ethnic differences.Results A total of 786 Chinese Han healthy children(486 males and 300 females) were enrolled into the study.In the study population,homozygous deletion(*0/*0) referring to slow metabolism was detected in 59.3%(n=466) for GSTM1 gene and 58.4%(n=459)for GSTT1 gene of the subjects,GSTM1 and GSTT1 homozygous deletions(*0/*0) respectively.The heterozygous deletion(*1/*0) referring to middle metabolism was detected in 34.0%(n=267) for GSTM1 gene and 35.1%(n=276) for GSTT1 gene of the subjects,respectively.The homozygote of non-deletion(*1/*1) referring to fast metabolism was detected in 6.7%(n= 53) for GSTM1 gene and 6.5%(n=51) for GSTT1 gene of the subjects,respectively.There was no co-expression of GSTM1 and GSTT1.And there were no significant statistical differences in gene copy number variation frequency between different genders.The comparisons of GSTM1 and GSTT1 gene genotype frequencies among worldwide populations showed different distribution patterns in Asians,Black and Caucasians.The homozygotes of deletion of the DNA fragments of interest for GSTM1 and GSTT1 gene were more common in Asia population.Conclusions In this study,GSTM1 and GSTT1 slow metabolism(indicated by *0/*0 genotype) was more prone in Chinese Han children.The distributions of GSTM1 and GSTT1 gene polymorphisms varied among different races or regions.It provided an important theoretical basis for formulate treatment plans which suitable for Chinese Han children aiming at the hepatic metabolism drugs.Meanwhile,individualized medical treatment may be fulfilled in Chinese Han children,such as antitubercular treatment.However,observing the frequencies of genetic polymorphism will be insufficient in the absence of any supporting clinical data on catalytic or functional activity concerning the effect of a given genetic variant on the future research,it is planed to present a complete analysis with respect to the role of these variants in influencing the serum levels and therapeutic efficacy of drugs.
What problem does this paper attempt to address?